DB05207ExperimentalSmall molecule
SD118 was previously under investigation in Japan for a different indication and now, following re-profiling and evaluation in experimental animal models, has demonstrated its potential as a new oral therapy...
- Mechanism
- Curator reviewed
Immune system modulator
- Primary indication
- Central Nervous System - Neuropathic painCurator reviewed
- Code names
- NSL-043 · SD118
Resolves to
Targets
What you can answer from here — as of March 06, 2025
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with SD118, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account